Primary FDA-Approved Indications
Guideline use includes mucosal candidiasis, candidemia step-down, and prophylaxis in immunocompromised hosts.
Oropharyngeal candidiasis
FDA ApprovedInfants and childrenRandomized trials
Evidence Sources
()
Esophageal candidiasis
FDA ApprovedChildrenRandomized trials
Candidemia (step-down therapy)
FDA ApprovedChildrenIDSA guideline